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Abstract
Background:  Tropane alkaloids, mainly hyoscyamine and scopolamine, are widely used in
medicine due to their anticholinergic activity. Scopolamine has a higher demand being the more
valuable alkaloid due to its fewer side effects and higher physiological activity. Anisodamine (6β-
hydroxyhyoscyamine) is the intermediate in the conversion of hyoscyamine into scopolamine.
Current studies report that this alkaloid is potentially applicable in medicine. The gene that codifies
for Hyoscyamine 6-β hydroxylase, the enzyme responsible for hyoscyamine hydroxylation and
epoxidation, leading to scopolamine was isolated from Brugmansia candida.
Results: The h6hcDNA was cloned into pYES2.1 and pYES2.1/V5-His-TOPO vectors to produce
an untagged and a tagged protein, respectively. The H6H enzyme was produced in Saccharomyces
cerevisiae  in order to obtain a biological catalyst for potential industrial applications. Protein
extracts of the induced yeast were analyzed by Western blot. The expression was detected 4 h
after induction and no degradation was observed during the period assayed. The tagged and the
untagged proteins were able to transform hyoscyamine, showing a functional expression of the
h6hcDNA.
Conclusion:  The strains obtained in this work are promising and potentially applicable in
biocatalytic processes.
Background
The tropane alkaloids hyoscyamine and scopolamine are
widely used as pharmaceuticals due to their anticholiner-
gic activity. The application of scopolamine in medicine is
preferred because of the fewer side effects produced and
higher physiological activity of this alkaloid. Anisodam-
ine, other tropane derivative, also presents pharmacologi-
cal properties, but is less potent and less toxic than the
other compounds. Anisodamine offers additional thera-
peutic applications such as the treatment of septic shock,
circulatory disorders, gastric ulcers, respiratory diseases,
gastrointestinal colic, organophosphorus poisoning,
migraine, acute glomerular nephritis, eclampsia and rheu-
matoid arthritis [1].
Fig. 1 shows the chemical structures of hyoscyamine, ani-
sodamine and scopolamine. Hyoscyamine 6-β hydroxy-
lase (H6H, EC 1.14.11.11), a plant enzyme, catalyses the
hyosacyamine hydroxylation producing 6β-hydroxyhyo-
scyamine (anisodamine) and then its epoxidation leading
to scopolamine (6,7-β-epoxide of hyoscyamine).
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Scopolamine is the most valuable, with a 10 times higher
commercial demand than that of hyoscyamine [2-7]. For
this reason the transformation processes is an attractive
strategy for anisodamine and scopolamine production.
Among the possible transformation processes, the bio-
conversion appears to be the preferable choice. The first
step in this direction is having an efficient system for
recombinant enzyme production. From this point of
view, Saccharomyces cerevisiae is a good candidate. This
yeast has been used for many biotechnological applica-
tions including the expression of recombinant proteins
[8]. It has also the ability to perform eukaryotic modifica-
tions and appropriate folding with the advantage of the
easy manipulation and the rapid growth usual in prokary-
otic cells [9]. In addition, S. cerevisiae is not pathogenic
and has been classified as GRAS (Generally Regarded as
Safe)[10]. The choice of this microorganism is also based
on the availability of a well known culture technology
with an easy scale-up.
The aim of this work is to obtain a S. cerevisiae strain har-
bouring the H6H plant enzyme for catalytic applications
in the production of scopolamine and/or 6β-hydroxyhyo-
scyamine. For this propose it is necessary to isolate the h6h
gene as a first step. Brugmansia candida (syn Datura cand-
ida) a tropane alkaloid producer plant [11], is a suitable
source for the isolation of h6h gene. The second step is
cloning this gene in S. cerevisiae and assesing the capacity




The amplification of the h6h cDNA was carried out by
PCR from total RNA preparations obtained from B. cand-
ida immature anthers as it was reported previously[12].
cDNAs encoding full-length H6H were cloned into the
yeast expression vectors pYES2.1/V5-His-TOPO and
pYES2.1 containing the GAL1 promoter as described in
Methods. The constructions obtained with the pYES2.1/
V5-His-TOPO vector were sequenced using Gal1 and V5C
primers from the TOPO cloning KIT and the pYES2.1 ones
with the specific primers mentioned in Methods section.
The sequences obtained for the B. candida h6h cDNA
(GenBank: EU530633) were highly homologue to the
Hyoscyamus niger h6h gene (Genbank: M62719)
H6h expression in S. cerevisiae
According to the vector used, two S. cerevisiae strains were
obtained. The YH6H 2-2 strain carries the pH6H2-2 vector
and the YpAC3-15(4) strain the pAC3-15 one. The induction
of the H6H expression was analyzed by sampling aliquots
at different times after culture induction according to
Methods. Yeast recombinant cells were lysed as described
and the protein extract was analyzed by Western blot. The
expression of the H6H enzyme as a fusion protein allowed
the detection of the fused epitope by commercially avail-
able antibodies. The H6H enzyme was produced in the
soluble form determined by Western blot. The production
of the H6H enzyme was detected 4 h after induction and
no degradation was observed during the time assayed
(Fig. 2).
Reactions catalyzed by H6H leading to 6β-hydroxyhyo- scyamine and scopolamine Figure 1
Reactions catalyzed by H6H leading to 6β-hydroxyhyo-
scyamine and scopolamine.Microbial Cell Factories 2008, 7:17 http://www.microbialcellfactories.com/content/7/1/17
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Enzyme activity
Different products were obtained depending on the
enzyme used in the activity assay (tagged or untagged
enzyme). Table 1 shows the percentages of the alkaloids
produced in the activity assays. When the reaction was
incubated for 2 hs, the tagged protein was able to produce
a 15% of 6β-hydroxyhyoscyamine. The other 85%
remained as hyoscyamine. On the other hand, the
untagged protein produced a 53.7% of the intermediate in
the same incubation time. Figure 3 shows the chromato-
grams obtained for each activity reaction at 15 h incuba-
tion. This time was arbitrarily elected and does not
indicate the end of bioconversion. The reaction carried
out with the tagged protein yielded on HPLC one product
with a retention time of 9.5 min comparable with 6beta-
hydroxyhyoscyamine (Fig. 3a). This protein was able to
produce approximately a 35.7% of 6β-hydroxyhyo-
scyamine in 15 h of incubation. In contrast, the reaction
carried out with the untagged enzyme yielded two prod-
ucts with retention times of 9.5 and 8.6 min on HPLC
(Fig. 3b). The later corresponds to the retention time of
scopolamine. In this case 83.3% of 6β-hydroxyhyo-
scyamine and 7.6% of scopolamine were produced. Only
a 9% of hyoscyamine was not transformed by the
untagged enzyme. No product formation was seen in con-
trol reactions performed with crude extract of induced
wild type strain (Fig 3c). Table 2 shows the activity of the
tagged and the untagged enzymes produced per mg of
total proteins of the crude extract. Comparing these results
to previous reports of the H6H, it can be noticed that the
activity of these preparations is of the same order of mag-
nitude and is superior to results obtained using the H6H
purified from hairy root extracts [13-15].
Discussion
The h6h cDNA was successfully amplified from immature
anthers from B. candida flower buttons.
Concerning to the sequences obtained, the results are
coincident with previous reports about the H6H from
other related species [13,14]. The 2OG-Fe (II) oxygenase
superfamily domain is also conserved in the h6h  gene
from  B. candida (GenBank: EU530633). This sequence
element that is considered to be an iron binding site is
also found in other 2-oxoglutarate dependent dioxygen-
ases from plant, bacteria and fungi [15,16]. In addition,
the sequence analysis shows that the h6h sequence has
similarity to other hydroxylases including those involved
in the biosynthesis of ethylene and anthocyanins[17].
Employing current methodologies of transformation of
yeast it was possible to obtain a recombinant S. cerevisiae
strain harboring the plant enzyme (H6H) with the aim to
obtain the biological catalyst for the conversion of hyo-
scyamine.
In order to follow the production of the H6H enzyme by
immunodetection with antibodies it was necessary to
incorporate an epitope to the recombinant protein for the
analysis.
The tagged enzyme was able to transform hyoscyamine
into 6β-hydroxyhyoscyamine while the untagged protein
transformed hyoscyamine into scopolamine and 6β-
hydroxyhyoscyamine, showing a functional expression of
the h6hcDNA. The activity of the enzyme produced in S.
cerevisiae was similar to previous reports about the activity
of other H6H [13,18]. The specific activity of the crude
extract from yeast has values of the same order of magni-
Western blot performed with cell lysates of S. cerevisiae producing the recombinant H6H enzyme from B. candida after differ- ent post-induction times: 0, 4, 8, 12, 16, 24, 27, 29 h Figure 2
Western blot performed with cell lysates of S. cerevisiae producing the recombinant H6H enzyme from B. candida after differ-
ent post-induction times: 0, 4, 8, 12, 16, 24, 27, 29 h.
Table 1: Alkaloids produced from hyoscyamine with the tagged 
and untagged H6H after 2 and 15 h of incubation.
6β-hydroxyhyoscyamine (%) Scopolamine (%)
Time (h) 2 15 2 15
Untagged H6H 53.7 83.3 - 7,6
Tagged H6H 15.0 35.7 - -
Negative control - - - -
The percentage values of 6β-hydroxyhyoscyamine and scopolamine 
are the means of three independent determinations which differs in 
no more than 10%Microbial Cell Factories 2008, 7:17 http://www.microbialcellfactories.com/content/7/1/17
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tude and even higher than previous reports (see Table 1).
Former publications referred the enzyme activity to puri-
fied H6H concentration. It should be kept in mind that
the results reported here are referred to total protein con-
centration of the crude extract. The results presented in
this work, showed that the epitope and the histidine tag
fused to the protein reduce the ability of the enzyme to
transform the alkaloid. This protein presented a lower rate
of conversion of hyoscyamine than the untagged enzyme.
Another advantage of the later is the ability to produce
scopolamine and not just 6β-hydroxyhyoscyamine within
the incubation times assayed. The differences observed
between the tagged and untagged enzymes could be
attributed to the flag. It is possible that the epitope and the
histidine tag affect in some way the enzyme activity, mod-
ifying the correct folding of the protein.
Being scopolamine the more valuable tropane alkaloid
several strategies were developed to increase its produc-
tion in plant systems. Two examples of this are the over-
expression of the h6h gene in Hyoscyamus muticus hairy
root [19] and the overexpression of the Putrescine N-
methyltransferase (PMT) and H6H in H. niger hairy root
[4]. However, the expression of plant genes in microor-
ganisms could be a useful and economically attractive
approach for the production of plant proteins and their
products. The main advantages that microorganisms have
over plant systems are that the production of biomass is
achieved quicker and that the genetic is well known [20].
Alkaloids are complex structures making chemical synthe-
sis complicated and expensive. For all these reasons,
microorganisms are considered an attractive alternative
for the production of alkaloids. There are several reports
about the microorganism production of plant enzymes
involved in alkaloid biosynthetic pathways [21-24]. In
addition, the production of the H6H in Escherichia coli for
functional studies has been described [13,15].
As far as the authors are aware, this is the first report about
the cloning of the h6h gene in S. cerevisiae. H6H is a key
enzyme from the tropane alkaloid pathway that allows
the production of scopolamine, which is a valuable alka-
loid with a demand calculated 10 times higher than its
precursor, hyoscyamine. In addition, this enzyme has the
ability of producing anisodamine which is promissory for
a therapeutic use [1].
Additionally, S. cerevisiae has certain advantages over E.
coli for pharmaceutical applications. The later produces
endotoxins and the use of S. cerevisiae is considered to be
safe, having a long history of application in the alimentary
and pharmaceutical industry.
Conclusion
According to the results obtained in this work, we can con-
clude that the recombinant strains obtained are promising
for the production of scopolamine and anisodamine by
biotransformation. Further studies are being performed




Immature anthers (microspore mother cells) from B. can-
dida  flower buttons were harvested at the "Jardín
Botánico" of Buenos Aires (Argentina).
Strains and vectors
E. coli strain DH5α (F-recA1  endA1  hsdR17 (rk-, mk+)
supE44 λ-thi-1 gyrA96 relA1) was maintained at 37°C in
Luria Bertani medium (LB) (Bacto-tryptone 10 g l-1, bacto-
yeast extract 5 g l-1, NaCl 10 g l-1). For recombinant strains
the media was supplemented with 100 μg ml-1 ampicillin.
S. cerevisiae strain CEN PK2 (Acc. n° 30000D, Eurofan)
(Mata/Matα ura3-Δ2/ura3-Δ2 trp1-289/trp1-289 leu2-3,
112/leu2-3, 112 his3Δ1/his3Δ1 mal2-8 C/mal2-8 C suc2/
suc2) was kindly supplied by Dr. Susana Silverstein, IFYB-
INE-FCEN UBA. S. cerevisiae wild type strain was grown in
YPD medium (10 g l-1yeast extract, 20 g l-1 peptone, 20 g
l-1 glucose) at 30°C. The recombinant yeast strains were
maintained in the selection medium YNBD-U (yeast
nitrogen base without uracil).
The pYES2.1/V5-His-TOPO and pYES2.1 vectors from
Invitrogen (California, USA) were used to insert the
h6hcDNA according to the manufacturer's instructions.
Table 2: Hydroxylase and epoxidase activities in crude protein extract of recombinant S. cerevisiae strains, YpAC3-15(4) and YH6H 2-2 
overexpressing the B. candida h6h gene.
Crude extract Hydroxylase activity Epoxidase activity
Specific Activity (nKat mg-1) Specific Activity (nKat mg-1)
Untagged H6H 2.60 ± 0.19 0.24 ± 0.02
Tagged H6H 0.89 ± 0.06 ND*
*ND: Not detectedMicrobial Cell Factories 2008, 7:17 http://www.microbialcellfactories.com/content/7/1/17
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HPLC chromatograms obtained after 15 h incubation Figure 3
HPLC chromatograms obtained after 15 h incubation. (a) Tagged protein. (b) Untagged protein. (c) Control reaction (carried 
out with a crude protein preparation of wild type cells).Microbial Cell Factories 2008, 7:17 http://www.microbialcellfactories.com/content/7/1/17
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Chemicals
L-Hyoscyamine hydrobromide, Scopolamine hydrobro-
mide and all the media components were purchased from
Sigma Chemical Co. (St. Louis, USA). Anisodamine (6β-
hydroxyhyoscyamine) was kindly provided by Dr. László
Kursinszki, Semmelweis University. Budapest, Hungary.
YNB medium and Catalase were purchased from from
ICN Biomedicals, Inc. (California, USA), PCR reagents
and the Anti V5 antibody by Invitrogen (California, USA),
ECL reagent from GE (Little Chalfont Buckinghamshire,
UK) and the Complete, EDTA-free Protease Inhibitor
Cocktail Tablets were supplied by ROCHE (Mannheim,
Germany).
Cloning of h6hcDNA
The h6h amplified PCR product of 1000 bp was gel puri-
fied and cloned into the pYES2.1/V5-His-TOPO and pYES
2.1 vectors containing the galactose-inducible glucose-
repressible GAL1 promoter. Specific primers were
designed based on the sequence of the H6H gene from H.
niger  (Genbank: M62719). The resulting primers were:
5'GACATTGATGGCTACTTTTGTGTCGAACTGG3' (for-
ward) and 5'ACGACCTTCGATATTGATTTTATATGGC3'
(reverse) for the pYES2.1/V5-His-TOPO vector. The
reverse primer eliminates the stop codon of the amplified






In the first case the PCR product is expressed as a fusion to
the C-terminal V5 epitope and poly-histidine tag. The
resulting recombinant plasmid named pAC3-15 and the
pH6H2-2 respectively were amplified in E. coli DH5α and
were sequenced on both strands.
DNA sequencing and sequence analysis
DNA sequencing was performed by Macrogen (Seoul,
Korea). The results were analysed using the BLAST algo-
rithm of the National Center for Biotechnology Informa-
tion (NCBI).
Yeast transformation and heterologous expression
S. cerevisiae strain CEN PK2 was used as host for the pAC3-
15 and the pH6H2-2 recombinant vectors. Yeast chemical
transformations were performed by the lithium acetate
protocol [25]. The clones obtained were grown at 30°C
on minimal medium YNBD-U supplemented with histi-
dine, leucine and tryptophane.
Recombinant yeast was grown for 16 h into YNBD-U
medium at 30°C, 200 rpm. For the H6H expression the
cells were separated by centrifugation, rinsed with dis-
tilled water and cultured again in the same medium con-
taining galactose 2% (YNBG-U media) instead of glucose.
Cells were harvested at 0, 4, 8, 12, 16, 24, 27 and 29 h after
induction.
Western blot analysis
Yeast transformant cells were lysed by shear forces using
acid-washed glass beads and protease inhibitor Cocktail
Tablets from Roche. The extent of lysis was checked with
small aliquots under the microscope. Proteins were meas-
ured by the Bradford method [26]. Aliquots of 50 μg of
protein lysate were loaded into a 12% poliacrylamide gel.
SDS-PAGE and Western blot were performed according to
the protocol described by Laemmli [27]. The protein was
revealed by chemiluminescent ECL reagents.
Enzyme activity assay
Crude preparations of the recombinant H6H were assayed
for the enzymatic activity by measuring the transforma-
tion of hyoscyamine. The 10 ml reaction mixture con-
tained 50 mM Tris-HCl buffer (pH7.8 at 30°C), 4 mM
sodium ascorbate, 0.4 mM FeSO4, 1 mM 2-oxoglutarate,
0.2 mM l-hyoscyamine hydrobromide, 500 μl catalase
[13,18]. The reaction was started by the addition of the
crude protein extract and was incubated at 30°C for 15 h.
All the glass materials used were treated with HNO3 to
eliminate traces residual metals and the experiments were
carried out by triplicate.
Alkaloid extraction
The alkaloid extraction of the reaction mixture mentioned
above was performed at pH 9. Samples were extracted
three times with 5 ml chloroform by vortexing and the
organic phase was evaporated under gaseous N2. The resi-
due was dissolved in methanol-water (50:50 v v-1) and fil-
tered trough a 0.45 μm pore nylon membrane.
Analytical Methods
HPLC analysis of the alkaloids was performed on a Shi-
madzu LC-20AT system with a LiChro CART column 125–
4 Lichrospher 60 RP-select B (5 μm), Merck (Darmstadt,
Germany). The elution was performed at 40°C, isocrati-
cally with Octanesulfonic acid 0.01 M pH3/Metanol
(65:35 v v-1) at a 1 ml min-1 flow rate. The detection was
performed at 220 nm.
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